Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a228e3ec4caecdd8

Jump to content

// Workers AI · dad joke modeWhat did PowderJect say? I'm blown away.

From Wikipedia, the free encyclopedia
(Redirected from PowderJect Pharmaceuticals)

PowderJect Pharmaceuticals was a British vaccine, drug and diagnostics delivery company founded by Brian Bellhouse. They developed a needle-free injection system for delivering medications and vaccines.

In 1993, PowderJect was spun out of the University of Oxford with the help of Isis Innovation.[1][2]

In 2003, the company was taken over by the American Chiron Corporation for £542 million.[3][4] The company's CEO was Paul Drayson, Baron Drayson, son-in-law of the founder, Brian Bellhouse, and they received £100 million following the takeover.[3][4] Drayson received £43m for his 8% holding, Bellhouse £19.5m for his 3.6% stake, and their family trusts received £41m.[4]

References

[edit]
  1. Elliott, Francis (14 April 2002). "Labour donor is no stranger to controversy". Telegraph. Retrieved 29 June 2017.
  2. Andrew Clark (19 January 2002). "Interview: Paul Drayson, Powderject Pharmaceuticals | Business". The Guardian. Retrieved 29 June 2017.
  3. 1 2 Fletcher, Richard (27 April 2003). "PowderJect to be sold for £500m". Daily Telegraph. UK. Retrieved 27 June 2017.
  4. 1 2 3 Geoffrey Gibbs (20 May 2003). "£43m windfall for PowderJect chief | Business". The Guardian. Retrieved 27 June 2017.